15.3. Research Methodology - 15.3.1. Secondary Research
- 15.3.2. Primary Research
- 15.3.3. Statistical Models
- 15.3.4. Research Limitations
List of Figures
Fig.1 Product Picture of Pharmacovigilance
Fig.2 Global Pharmacovigilance Market, 2016 – 2026 (USD Million)
Fig.3 Global Pharmacovigilance Market Absolute Revenue Opportunity, 2016 – 2026 (USD Million)
Fig.4 Global Pharmacovigilance Market Incremental Revenue Opportunity, 2020 – 2026 (USD Million)
Fig.5 Global Pharmacovigilance Market Share, by Service Provider, 2019 & 2026 (USD Million)
Fig.6 Global In-house Pharmacovigilance Market, 2016 – 2026 (USD Million)
Fig.7 Global Contract Outsourcing Pharmacovigilance Market, 2016 – 2026 (USD Million)
Fig.8 Global Pharmacovigilance Market Share, by Product Life Cycle, 2019 & 2026 (USD Million)
Fig.9 Global Pre-clinical Pharmacovigilance Market, 2016 – 2026 (USD Million)
Fig.10 Global Phase I Pharmacovigilance Market, 2016 – 2026 (USD Million)
Fig.11 Global Phase II Pharmacovigilance Market, 2016 – 2026 (USD Million)
Fig.12 Global Phase III Pharmacovigilance Market, 2016 – 2026 (USD Million)
Fig.13 Global Phase IV Pharmacovigilance Market, 2016 – 2026 (USD Million)
Fig.14 Global Pharmacovigilance Market Share, by Type, 2019 & 2026 (USD Million)
Fig.15 Global Spontaneous Reporting Pharmacovigilance Market, 2016 – 2026 (USD Million)
Fig.16 Global Intensified ADR Reporting Pharmacovigilance Market, 2016 – 2026 (USD Million)
Fig.17 Global Targeted Spontaneous Reporting Pharmacovigilance Market, 2016 – 2026 (USD Million)
Fig.18 Global Cohort Event Monitoring Pharmacovigilance Market, 2016 – 2026 (USD Million)
Fig.19 Global EHR Mining Pharmacovigilance Market, 2016 – 2026 (USD Million)
Fig.20 Global Pharmacovigilance Market Share, by Process Flow, 2019 & 2026 (USD Million)
Fig.21 Global Case Data Management Pharmacovigilance Market, 2016 – 2026 (USD Million)
Fig.22 Global Signal Detection Pharmacovigilance Market, 2016 – 2026 (USD Million)
Fig.23 Global Risk Management System Pharmacovigilance Market, 2016 – 2026 (USD Million)
Fig.24 Global Pharmacovigilance Market Share, by Therapeutic Area, 2019 & 2026 (USD Million)
Fig.25 Global Oncology Pharmacovigilance Market, 2016 – 2026 (USD Million)
Fig.26 Global Neurology Pharmacovigilance Market, 2016 – 2026 (USD Million)
Fig.27 Global Cardiology Pharmacovigilance Market, 2016 – 2026 (USD Million)
Fig.28 Global Respiratory Systems Pharmacovigilance Market, 2016 – 2026 (USD Million)
Fig.29 Global Others Pharmacovigilance Market, 2016 – 2026 (USD Million)
Fig.30 Global Pharmacovigilance Market Share, by End user, 2019 & 2026 (USD Million)
Fig.31 Global Pharmaceuticals Pharmacovigilance Market, 2016 – 2026 (USD Million)
Fig.32 Global Biotechnology Companies Pharmacovigilance Market, 2016 – 2026 (USD Million)
Fig.33 Global Medical Device Manufacturers Pharmacovigilance Market, 2016 – 2026 (USD Million)
Fig.34 Global Others Pharmacovigilance Market, 2016 – 2026 (USD Million)
Fig.35 Global Pharmacovigilance Market Share, by Region, 2019 & 2026 (USD Million)
Fig.36 North America Pharmacovigilance Market, 2016 – 2026 (USD Million)
Fig.37 U.S. Pharmacovigilance Market, 2016 – 2026 (USD Million)
Fig.38 Canada Pharmacovigilance Market, 2016 – 2026 (USD Million)
Fig.39 Europe Pharmacovigilance Market, 2016 – 2026 (USD Million)
Fig.40 Germany Pharmacovigilance Market, 2016 – 2026 (USD Million)
Fig.41 France Pharmacovigilance Market, 2016 – 2026 (USD Million)
Fig.42 U.K. Pharmacovigilance Market, 2016 – 2026 (USD Million)
Fig.43 Italy Pharmacovigilance Market, 2016 – 2026 (USD Million)
Fig.44 Spain Pharmacovigilance Market, 2016 – 2026 (USD Million)
Fig.45 Rest of Europe Pharmacovigilance Market, 2016 – 2026 (USD Million)
Fig.46 Asia Pacific Pharmacovigilance Market, 2016 – 2026 (USD Million)
Fig.47 China Pharmacovigilance Market, 2016 – 2026 (USD Million)
Fig.48 Japan Pharmacovigilance Market, 2016 – 2026 (USD Million)
Fig.49 India Pharmacovigilance Market, 2016 – 2026 (USD Million)
Fig.50 South Korea Pharmacovigilance Market, 2016 – 2026 (USD Million)
Fig.51 South-East Asia Pharmacovigilance Market, 2016 – 2026 (USD Million)
Fig.52 Rest of Asia Pacific Pharmacovigilance Market, 2016 – 2026 (USD Million)
Fig.53 Latin America Pharmacovigilance Market, 2016 – 2026 (USD Million)
Fig.54 Brazil Pharmacovigilance Market, 2016 – 2026 (USD Million)
Fig.55 Mexico Pharmacovigilance Market, 2016 – 2026 (USD Million)
Fig.56 Rest of Latin America Pharmacovigilance Market, 2016 – 2026 (USD Million)
Fig.57 The Middle-East and Africa Pharmacovigilance Market, 2016 – 2026 (USD Million)
Fig.58 GCC Countries Pharmacovigilance Market, 2016 – 2026 (USD Million)
Fig.59 South Africa Pharmacovigilance Market, 2016 – 2026 (USD Million)
Fig.60 Rest of Middle-East Africa Pharmacovigilance Market, 2016 – 2026 (USD Million)
Fig.61 Competitor Market Share – Revenue
Fig.62 Wipro Ltd Revenue and Growth Rate
Fig.63 Wipro Ltd Market Share
Fig.64 United BioSource Corporation Revenue and Growth Rate
Fig.65 United BioSource Corporation Market Share
Fig.66 TAKE Solutions Ltd. Revenue and Growth Rate
Fig.67 TAKE Solutions Ltd. Market Share
Fig.68 PAREXEL International Corporation Revenue and Growth Rate
Fig.69 PAREXEL International Corporation Market Share
Fig.70 Linical Accelovance Revenue and Growth Rate
Fig.71 Linical Accelovance Market Share
Fig.72 Laboratory Corporation of America Holdings Revenue and Growth Rate
Fig.73 Laboratory Corporation of America Holdings Market Share
Fig.74 ITClinical Revenue and Growth Rate
Fig.75 ITClinical Market Share
Fig.76 IQVIA Revenue and Growth Rate
Fig.77 IQVIA Market Share
Fig.78 ICON PLC Revenue and Growth Rate
Fig.79 ICON PLC Market Share
Fig.80 IBM Corporation Revenue and Growth Rate
Fig.81 IBM Corporation Market Share
Fig.82 Foresight Group International AG Revenue and Growth Rate
Fig.83 Foresight Group International AG Market Share
Fig.84 FMD K&L Inc. Revenue and Growth Rate
Fig.85 FMD K&L Inc. Market Share
Fig.86 Cognizant Revenue and Growth Rate
Fig.87 Cognizant Market Share
Fig.88 Capgemini Revenue and Growth Rate
Fig.89 Capgemini Market Share
Fig.90 BioClinica Revenue and Growth Rate
Fig.91 BioClinica Market Share
Fig.92 ArisGlobal Revenue and Growth Rate
Fig.93 ArisGlobal Market Share
Fig.94 Accenture Revenue and Growth Rate
Fig.95 Accenture Market Share
Fig.96 Market Dynamics
Fig.97 Global Pharmacovigilance – Value Chain Analysis
Fig.98 Key Mandates and Regulations
Fig.99 Technology Roadmap and Timeline
Fig.100 Market Attractiveness Analysis – By Service Provider
Fig.101 Market Attractiveness Analysis – By Product Life Cycle
Fig.102 Market Attractiveness Analysis – By Type
Fig.103 Market Attractiveness Analysis – By Process Flow
Fig.104 Market Attractiveness Analysis – By Therapeutic Area
Fig.105 Market Attractiveness Analysis – By End user
Fig.106 Market Attractiveness Analysis – By Region
Fig.107 Pharmacovigilance Industrial Chain Analysis
Fig.108 Market Channels
Fig.109 Marketing Channel Development Trend
Fig.110 Growth in World Gross Product, 2008-2018
List of Tables
Table 1 Global Pharmacovigilance Market, 2019 & 2026 (USD Million)
Table 2 Global Pharmacovigilance Market, by Service Provider, 2016 – 2026 (USD Million)
Table 3 Global Pharmacovigilance Market, by Product Life Cycle, 2016 – 2026 (USD Million)
Table 4 Global Pharmacovigilance Market, by Type, 2016 – 2026 (USD Million)
Table 5 Global Pharmacovigilance Market, by Process Flow, 2016 – 2026 (USD Million)
Table 6 Global Pharmacovigilance Market, by Therapeutic Area, 2016 – 2026 (USD Million)
Table 7 Global Pharmacovigilance Market, by End user, 2016 – 2026 (USD Million)
Table 8 Global Pharmacovigilance Market, by Region, 2016 – 2026 (USD Million)
Table 9 North America Pharmacovigilance Market, by Country, 2016 – 2026 (USD Million)
Table 10 North America Pharmacovigilance Market, by Service Provider, 2016 – 2026 (USD Million)
Table 11 North America Pharmacovigilance Market, by Product Life Cycle, 2016 – 2026 (USD Million)
Table 12 North America Pharmacovigilance Market, by Type, 2016 – 2026 (USD Million)
Table 13 North America Pharmacovigilance Market, by Process Flow, 2016 – 2026 (USD Million)
Table 14 North America Pharmacovigilance Market, by Therapeutic Area, 2016 – 2026 (USD Million)
Table 15 North America Pharmacovigilance Market, by End user, 2016 – 2026 (USD Million)
Table 16 Europe Pharmacovigilance Market, by Country, 2016 – 2026 (USD Million)
Table 17 Europe Pharmacovigilance Market, by Service Provider, 2016 – 2026 (USD Million)
Table 18 Europe Pharmacovigilance Market, by Product Life Cycle, 2016 – 2026 (USD Million)
Table 19 Europe Pharmacovigilance Market, by Type, 2016 – 2026 (USD Million)
Table 20 Europe Pharmacovigilance Market, by Process Flow, 2016 – 2026 (USD Million)
Table 21 Europe Pharmacovigilance Market, by Therapeutic Area, 2016 – 2026 (USD Million)
Table 22 Europe Pharmacovigilance Market, by End user, 2016 – 2026 (USD Million)
Table 23 Asia Pacific Pharmacovigilance Market, by Country, 2016 – 2026 (USD Million)
Table 24 Asia Pacific Pharmacovigilance Market, by Service Provider, 2016 – 2026 (USD Million)
Table 25 Asia Pacific Pharmacovigilance Market, by Product Life Cycle, 2016 – 2026 (USD Million)
Table 26 Asia Pacific Pharmacovigilance Market, by Type, 2016 – 2026 (USD Million)
Table 27 Asia Pacific Pharmacovigilance Market, by Process Flow, 2016 – 2026 (USD Million)
Table 28 Asia Pacific Pharmacovigilance Market, by Therapeutic Area, 2016 – 2026 (USD Million)
Table 29 Asia Pacific Pharmacovigilance Market, by End user, 2016 – 2026 (USD Million)
Table 30 Latin America Pharmacovigilance Market, by Country, 2016 – 2026 (USD Million)
Table 31 Latin America Pharmacovigilance Market, by Service Provider, 2016 – 2026 (USD Million)
Table 32 Latin America Pharmacovigilance Market, by Product Life Cycle, 2016 – 2026 (USD Million)
Table 33 Latin America Pharmacovigilance Market, by Type, 2016 – 2026 (USD Million)
Table 34 Latin America Pharmacovigilance Market, by Process Flow, 2016 – 2026 (USD Million)
Table 35 Latin America Pharmacovigilance Market, by Therapeutic Area, 2016 – 2026 (USD Million)
Table 36 Latin America Pharmacovigilance Market, by End user, 2016 – 2026 (USD Million)
Table 37 The Middle-East and Africa Pharmacovigilance Market, by Country, 2016 – 2026 (USD Million)
Table 38 The Middle-East and Africa Pharmacovigilance Market, by Service Provider, 2016 – 2026 (USD Million)
Table 39 The Middle-East and Africa Pharmacovigilance Market, by Product Life Cycle, 2016 – 2026 (USD Million)
Table 40 The Middle-East and Africa Pharmacovigilance Market, by Type, 2016 – 2026 (USD Million)
Table 41 The Middle-East and Africa Pharmacovigilance Market, by Process Flow, 2016 – 2026 (USD Million)
Table 42 The Middle-East and Africa Pharmacovigilance Market, by Therapeutic Area, 2016 – 2026 (USD Million)
Table 43 The Middle-East and Africa Pharmacovigilance Market, by End user, 2016 – 2026 (USD Million)
Table 44 Global Pharmacovigilance Market - Company Revenue Analysis, 2016 – 2019 (USD Million)
Table 45 Global Pharmacovigilance Market - Company Revenue Share Analysis, 2016 – 2019 (%)
Table 46 Acquisitions and Mergers
Table 47 Market Drivers – Impact Analysis
Table 48 Market Restraints
Table 49 Market Opportunities
Table 50 Major Buyers of Pharmacovigilance
Table 51 Distributors/Traders of Pharmacovigilance by Region